AR‐ and PTEN‐proficient prostate cancer cell lines (CWR22Res, CWR22RV1 and VCaP) showed significantly enhanced expression of AR variants including ARV7 (Figs EV1K and EV2B). This evidence concerns the gene PTEN and Familial prostate cancer.